Citation
89 FR 17475
Multiple canonical documents share this first-page citation.
- Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment; Guidance for Industry; Correction Monday, March 11, 2024 89 FR 17475
- Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability Monday, March 11, 2024 89 FR 17475